Medical Weight Loss for Paterson, New Jersey Residents

Paterson, New Jersey residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Paterson through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Wondering if you qualify in Paterson? Eligibility for compounded GLP-1 care is confirmed by Dr. Sharma during your video visit, based on your health history, not your zip code in New Jersey. Doctor review just $119 (medication separate).

Why Paterson Residents Choose New Hope Weight Loss

You never have to leave Paterson to work with us. The entire program runs by telehealth from our clinic in Costa Mesa, California, so your consultation, your follow-ups, and your dose adjustments all happen by video and message from wherever you are in New Jersey. Whether you live near Downtown, the Great Falls area, and the greater Passaic County area or further out, the care is identical. No commute, no waiting room, no rearranging your week around an appointment across town.

Paterson residents do not need a local clinic to start. Our physician-led program is delivered by secure video from Costa Mesa, California, with flat nationwide pricing and compounded medication mailed in cold-pack packaging to your Paterson address.

From the first visit to your refills, people in Paterson, New Jersey are cared for by Dr. Sharma through telehealth, so the only thing missing is the commute to Costa Mesa. We care for patients throughout Downtown, the Great Falls area, and the greater Passaic County area. From your first question to your ongoing refills, the whole New Jersey experience is built to feel personal, private, and genuinely supported.

By handling visits through telehealth, we serve every neighborhood in Paterson, from Downtown, the Great Falls area, and the greater Passaic County area, without asking anyone to travel. If you and Dr. Sharma decide tirzepatide fits your goals, Paterson patients can begin from $233 per month, billed apart from your initial $119 visit. New Jersey is one of the most densely populated states in the country, and New Hope Weight Loss serves patients across it by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Compounded GLP-1 care, supervised by a physician

The 90-Day Metabolic Reset is built on semaglutide, the same active ingredient you will find in Wegovy and Ozempic. It is priced from $166/mo, with the complete 90-day program at $499, and branded-drug trials averaged about 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved, not brand-identical, and results vary by person. Dr. Sharma manages your care by telehealth, wherever you are in Paterson.

Prefer the dual-action route? Tirzepatide

From $233/mo, tirzepatide works on GLP-1 and GIP together. In branded-drug trials, dose-qualified patients reached up to 22.5 percent loss, a peak number that is not typical. Same active ingredient as Mounjaro and Zepbound.

It all starts with a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Paterson

Telehealth means your weight-loss care travels to you instead of the other way around. Patients across Paterson and the rest of start with a detailed online quiz covering medical history and goals. Dr. Anjmun Sharma personally reviews each intake and connects by secure video, usually inside 48 hours, to decide together whether a compounded GLP-1 is right. When she writes a prescription, the medication is filled by a state-licensed 503(a) pharmacy and mailed to your Paterson door in temperature-controlled cold-pack packaging. Ongoing follow-ups also happen by video, keeping your plan on track without a single in-person appointment.

Frequently Asked Questions, Paterson

I am searching for weight loss care near Paterson. Where are you?

We are based in Costa Mesa, California, where our only physical clinic operates. Patients in Paterson, New Jersey connect with us by telehealth instead of visiting. Dr. Anjmun Sharma conducts a video consult to review your goals and confirm whether you qualify for a compounded GLP-1 medication program.

Do I need to be seen in person if I live in Paterson?

Not at all. The telehealth format covers Paterson patients from start to finish, so no clinic visit is ever required. You speak with Dr. Sharma by video, and once you are approved, compounded medication ships to Paterson in cold-pack packaging built to keep it cool and stable.

What are the program costs for Paterson patients?

The physician review is priced at $119. Compounded semaglutide is available from $166 a month or $499 for the 90-day plan, and tirzepatide from $233 a month. Medication is invoiced separately. Payment options include HSA, FSA, Klarna, and Affirm, and Paterson patients face no distance surcharge.

What areas of Paterson do you serve?

We serve patients from across Paterson by telehealth, including Downtown, the Great Falls area, and the greater Passaic County area.

Are there hidden fees for Paterson patients?

No. Paterson patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.

Paterson Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Paterson, New Jersey by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.